Safety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALS

The Safety and Effectiveness of Cholinergic Receptor Block Therapy in the Treatment of ALS

NCT04391361 ·Status: UNKNOWN ·Phase: PHASE2

A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)

NCT01281631 ·Status: COMPLETED ·Phase: PHASE2

Clenbuterol on Motor Function in Individuals With Amyotrophic Lateral Sclerosis

NCT04245709 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate, Safety, Tolerability, Pharmacodynamic (PD) Markers and Pharmacokinetics (PK) of AP-101 in Participants With Amyotrophic Lateral Sclerosis (ALS)

NCT05039099 ·Status: COMPLETED ·Phase: PHASE2

Efficacy, Safety, and Pharmacokinetics of ES-481 in Adult Patients With Essential Tremors

NCT05234762 ·Status: UNKNOWN ·Phase: PHASE2

Safety and Tolerability Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS)

NCT00647296 ·Status: COMPLETED ·Phase: PHASE2

Open-Label, Safety and Tolerability Extension Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) (CL211)

NCT00931944 ·Status: COMPLETED ·Phase: PHASE2

A Safety and Tolerability Study of Intracerebroventricular Administration of sNN0029 to Patients With Amyotrophic Lateral Sclerosis

NCT00800501 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT04944784 ·Status: TERMINATED ·Phase: PHASE3

Safety and Efficacy of Albuterol in Individuals With Late-onset Pompe Disease

NCT01885936 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study of NMDA Antagonists and Neuropathic Pain

NCT01602185 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Amisodin in Healthy Adult Subjects With Amyotrophic Lateral Sclerosis

NCT07221240 ·Status: RECRUITING ·Phase: PHASE1

Double-Blind, Placebo Controlled Pilot Study of Octanoic Acid in Essential Tremor

NCT00848172 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Adenosine 2A Receptor Antagonism and AIH in ALS

NCT05377424 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury

NCT00557973 ·Status: COMPLETED ·Phase: PHASE2

A Study Evaluating the Safety and Tolerability of QRL-201 in ALS

NCT05633459 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Pivotal Study of N-acetyl-L-leucine for CACNA1A

NCT07221292 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Dose Titration Study to Test Safety and Effects of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT01486849 ·Status: COMPLETED ·Phase: PHASE2

A Study to Determine the Safety, Pharmacokinetics, and Pharmacodynamics of DNL343 in Participants With Amyotrophic Lateral Sclerosis

NCT05006352 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Nitrazine in the Treatment of ALS

NCT04950647 ·Status: UNKNOWN ·Phase: PHASE2

Arimoclomol in Amyotropic Lateral Sclerosis

NCT03491462 ·Status: COMPLETED ·Phase: PHASE3

Identifying and Treating Arousal Related Deficits in Neglect and Dysphagia

NCT01085903 ·Status: COMPLETED ·Phase: PHASE2

1-Octanol to Treat Essential Tremor

NCT00001986 ·Status: COMPLETED ·Phase: PHASE1

Study to Investigate the Safety and Efficacy of Lithium in Volunteers With Amyotrophic Lateral Sclerosis (ALS)

NCT00818389 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Study to Evaluate the Safety & Efficacy of FLX-787-ODT to Treat Fasciculations in Tongue and Upper or Lower Extremity Muscles Most Affected in Subjects With ALS

NCT03338114 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2